Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Ribonucleoside reductase inhibitors with anti-HIV activity in development at Molecules for Health

May 26, 1999

Protein Design Labs and Progenics enter humanization agreement for anti-CCR5 antibody

May 21, 1999

Independent DSMB recommends conclusion of Remune phase III trial

May 20, 1999

Takeda reports discovery of TAK-779, a potent anti-HIV agent with a novel mechanism

May 17, 1999

Second HIV fusion inhibitor developed at Trimeris given fast track designation

May 17, 1999

RB-2121, an anti-HIV agent directed to a novel antiretroviral target

May 14, 1999

Phase III trial results presented for Leukine in AIDS

May 14, 1999

Triangle, Glaxo Wellcome and Emory University resolve emtricitabine dispute

May 13, 1999

Hollis-Eden initiates phase I/II AIDS trial, reports preclinical results

May 12, 1999

Gilead extends Preveon expanded access program internationally

May 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...